There are more chemotherapy regimens after pancreatic cancer surgery, such as gemcitabine + capecitabine regimen, gemcitabine + albumin paclitaxel regimen, FOLFIRINOX regimen, oral tegeo, etc. The choice of chemotherapy regimen depends on the patient’s radical pancreatic cancer surgery; at the same time, these chemotherapy regimens usually have heavier adverse effects, so it also depends on the patient’s physical condition, whether he can tolerate The choice of these chemotherapy regimens is also based on the patient’s physical condition and whether he/she can tolerate chemotherapy. Overall, after pancreatic cancer surgery, chemotherapy is not particularly good. If the patient’s financial condition allows, he or she can be enrolled in a clinical trial of a new drug and try it out.